P

Active Director Director DIN 07294691
DIN 07294691 First appointment Sep 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Pardeep

Data last updated:

Pardeep is a Director at Alvis Medi Synthesis Private Limited (since 2015). The company operates in Chemicals. Alvis Medi Synthesis Private Limited reported revenue of ₹91.4 Lakh (FY 2025).

DIN 07294691
Primary Designation Director
Industry Chemicals
First Appointment 22 Sep 2015
Oldest Company Age 16 yrs
Largest company Alvis Medi Synthesis Private Limited · ₹91.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alvis Medi Synthesis Private Limited U24232HR2010PTC041165
Director22 Sep 20152010₹91.4 Lakh (FY 2025)Active

Board colleagues of Pardeep

Directorship timeline

Open interactive timeline →
Alvis Medi Synthesis Private Limited
Premium access

Shareholding and investment profile for Pardeep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pardeep

Pardeep currently holds 1 directorship: Alvis Medi Synthesis Private Limited (Director, since 22 Sep 2015, revenue ₹91.4 Lakh (FY 2025)).

Pardeep was first appointed on 22 Sep 2015 as Director at Alvis Medi Synthesis Private Limited.

The current boards of Pardeep's companies include Jeevan Kumar (Alvis Medi Synthesis Private Limited), Pushpa Devi (Alvis Medi Synthesis Private Limited), Vinod (Alvis Medi Synthesis Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available